Illumina Inc.

Price Chart

Risk-Adjusted Performance

Also Listed On

Illumina Inc. (I1LM34) Price Performance

Illumina Inc. (I1LM34) trades on SA in BRL. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at BRL129.11.

Over the past year, I1LM34 has traded between a low of BRL84.12 and a high of BRL159.36. The stock has gained 29.2% over this period. It is currently 19.0% below its 52-week high.

Illumina Inc. has a market capitalization of $98.70B.

About Illumina Inc.

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.